Mindray Medical Leads Institutional Research Focus — 356 Firms Conduct Due Diligence

China's Institutional Investors Flock to Medical Device and Chip Stocks

China's institutional investors have significantly increased their research activity, with Mindray Medical emerging as the most-watched company this week, attracting due diligence from 356 institutions, according to Wind data.

Top Research Targets

Sector Focus

Institutions are concentrating on three key sectors:

1. Medical and healthcare — Led by Mindray Medical, reflecting growing interest in China's medical device sector as the population ages
2. Electronic components — Including chip design companies like Montage Technology
3. Integrated circuits — Semiconductor companies continue to attract institutional capital

Notable Patterns

• Eastern Tantalum (东方钽业) received the most research visits with 10 separate sessions
• Sinotruk (中国重汽) was visited 5 times, indicating commercial vehicle sector interest
• Junxin Shares (军信股份) and Goldwind (金风科技) each received 4 visits

What This Signals

Heavy institutional research activity often precedes significant investment decisions. The concentration on medical devices and semiconductors suggests:

• Confidence in China's domestic medical device substitution trend
• Continued institutional appetite for semiconductor exposure despite geopolitical risks
• A rotation toward "hard tech" sectors as the AI investment cycle matures

Mindray Medical Profile

Mindray is China's largest medical device manufacturer, specializing in patient monitoring, in-vitro diagnostics, and medical imaging. The company has been a key beneficiary of China's policy to increase domestic medical device procurement.

Source: Wind Data, 36kr, First Financial News